EUVIMEDEUVIMED entdecken
Crossref

PARP inhibitor boost the efficacy of photothermal therapy to TNBC through enhanced DNA damage and inhibited homologous recombination repair

Yang Li, Wenfang Miao, Chen Yuan, Jiajia Tang, Nan Zhong, Yingying Jin, Yongzhi Hu, Yuxia Tang, Shouju Wang iD

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01650-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Yang Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Imaging, Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, 300, Guangzhoulu, Nanjing, Jia…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Phthalazines, Photothermal Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Natural Science Research of Jiangsu Higher Education Institutions of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) could benefit from PARP inhibitors (PARPi) for their frequent defective homologous recombination repair (HR). However, the efficacy of PARPi is limited by their lower bioavailability and high susceptibility to drug resistance, so it often needs to be combined with other treatments. Herein, polydopamine nanoparticles (PDMN) were constructed to load Olaparib (AZD) as two-channel therapeutic nanoplatforms. The PDMN has a homogeneous spherical structure around 100 nm and exhibits a good photothermal conversion efficiency of 62.4%. The obtained AZD-loaded nanoplatform (PDMN-AZD) showed enhanced antitumor effects through the combination of photothermal therapy (PTT) and PARPi. By western blot and flow cytometry, we found that PTT and PARPi could exert synergistic antitumor effects by further increasing DNA double-strand damage (DSBs) and enhancing HR defects. The strongest therapeutic effect of PDMN-AZD was observed in a BRCA-deficient mouse tumor model. In conclusion, the PDMN-AZD nanoplatform designed in this study demonstrated the effectiveness of PTT and PARPi for synergistic treatment of TNBC and preliminarily explained the mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsPoly(ADP-ribose) Polymerase InhibitorsPhthalazinesPhotothermal TherapyRecombinational DNA RepairPiperazinesAnimalsFemaleHumansIndolesCell Line, TumorNanoparticlesMiceDNA DamagePolymersMice, Inbred BALB CMice, Nude

Stichwörter der Autor:innen

DNA damagePhotothermal therapyPolydopamine nanoparticlesSynergistic treatmentTriple-negative breast cancer

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsPhthalazinesolaparibIndolesPiperazinespolydopaminePolymers

Autor:innen und Institutionen

  • Laboratory of Molecular Imaging, Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, 300, Guangzhoulu, Nanjing, Jiangsu, China.
  • Laboratory of Molecular Imaging, Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, 300, Guangzhoulu, Nanjing, Jiangsu, China. shouju.wang@gmail.com.

ORCID-Profile: Shouju Wang

Förderung

  • the National Natural Science Foundation of China
  • Natural Science Research of Jiangsu Higher Education Institutions of China

Zitieren

APA

Li, Y., Miao, W., Yuan, C., Tang, J., Zhong, N., Jin, Y., Hu, Y., Tang, Y., & Wang, S. (2025). PARP inhibitor boost the efficacy of photothermal therapy to TNBC through enhanced DNA damage and inhibited homologous recombination repair. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01650-6

Vancouver

Li Y, Miao W, Yuan C, Tang J, Zhong N, Jin Y, et al. PARP inhibitor boost the efficacy of photothermal therapy to TNBC through enhanced DNA damage and inhibited homologous recombination repair. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01650-6

BibTeX
@article{Li2025,
  author = {Li, Yang and Miao, Wenfang and Yuan, Chen and Tang, Jiajia and Zhong, Nan and Jin, Yingying and Hu, Yongzhi and Tang, Yuxia and Wang, Shouju},
  title = {PARP inhibitor boost the efficacy of photothermal therapy to TNBC through enhanced DNA damage and inhibited homologous recombination repair},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01650-6}
}
Kostenlos starten →